REZALTIMO Trademark

Trademark Overview


On Monday, July 28, 2014, a trademark application was filed for REZALTIMO with the United States Patent and Trademark Office. The USPTO has given the REZALTIMO trademark a serial number of 86349779. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 1, 2022. This trademark is owned by Glaxo Group Limited. The REZALTIMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rezaltimo

General Information


Serial Number86349779
Word MarkREZALTIMO
Filing DateMonday, July 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 1, 2022
Registration Number4816086
Registration DateTuesday, September 22, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, April 1, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, September 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 11, 2015ASSIGNED TO LIE
Wednesday, May 6, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 17, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 17, 2014LETTER OF SUSPENSION E-MAILED
Monday, November 17, 2014SUSPENSION LETTER WRITTEN
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 31, 2014NEW APPLICATION ENTERED IN TRAM